Lantheus names new CMO

AuntMinnie.com staff writers
Apr 5, 2022
2019 12 19 00 53 5252 Hands Shaking Deal 400

Lantheus Medical Imaging parent company Lantheus Holdings has appointed Dr. Jean-Claude Provost as interim chief medical officer (CMO). His appointment is effective immediately.

With more than 30 years of experience in international development of therapeutic drugs and diagnostic agents, Provost joins Lantheus from his pharmaceutical and biotechnology consultant firm, Theranostics Consulting.

Latest in Clinical News
2024 04 25 Radio Graphics Robb Figure7 Thumbnail
Understanding CT flow artifacts is key to better disease diagnosis
April 26, 2024
Liver Cancer
Dual-tracer PET/CT shows promise in liver cancer patients
April 26, 2024
We care about what you think.
Sponsored
We care about what you think.
October 30, 2023
Chat Gpt Artificial Intelligence Ai Head
ChatGPT-4 not reliable in cancer patient messaging
April 25, 2024
Related Stories
Fda Sign Dc
Ultrasound
FDA clears Lantheus' Definity for pediatric patients
2021 01 16 00 14 5464 Prostate Cancer 400
Nuclear Medicine
Lantheus to tout studies at upcoming SNMMI 2023 meeting
2022 10 21 23 21 9342 Prostate Cancer 3 D Rendering 400
Radiation Oncology/Therapy
Lantheus secures FDA fast track designation for prostate cancer drug
We care about what you think.
Sponsor Content
We care about what you think.
More in Clinical News
Understanding CT flow artifacts is key to better disease diagnosis
By Kate Madden Yee
Understanding the mechanics of flow artifacts on CT or CT angiography and how these artifacts are created is key to better disease diagnosis.
April 26, 2024
2024 04 25 Radio Graphics Robb Figure7 Thumbnail
Dual-tracer PET/CT shows promise in liver cancer patients
By Will Morton
Dual-tracer PET/CT appears valuable for improving tumor staging in patients with hepatocellular carcinoma being evaluated for treatment.
April 26, 2024
Liver Cancer
Studies lacking for trans breast cancer screening trends
By Amerigo Allegretto
There are limited studies examining breast cancer screening trends in transgender people.
April 25, 2024
Transgender Pride Symbol Social
ChatGPT-4 not reliable in cancer patient messaging
By Amerigo Allegretto
ChatGPT-4 is not a reliable source for answering patients’ questions regarding cancer and needs physician monitoring.
April 25, 2024
Chat Gpt Artificial Intelligence Ai Head
CT reveals influence of diabetes on COVID-19 severity
By Kate Madden Yee
CT imaging reveals the influence of blood glucose levels on the severity of COVID-19, researchers have reported.
April 25, 2024
3 D Lungs Covid Virus Cells
Clinical practice LCS program finds more disease than NLST
By Kate Madden Yee
A clinical practice lung cancer screening (LCS) program at Duke University Medical Center found more disease than did the National Lung Screening Trial (NLST).
April 24, 2024
Lung Illustration Blue
SPECT/CT predicts foot amputations in diabetics
By Will Morton
Technetium-99m white blood cell SPECT/CT imaging may be useful for identifying diabetic patients at risk of amputations due to foot infections.
April 24, 2024
Examples in two patients. (Top) Abnormal leukocyte accumulation was observed in the right 1st to 5th toes, with the radioactive lesions extending to the bone, indicating osteomyelitis (left panel, MIP image; right panel, axial SPECT/CT). Two spherical VOIs were drawn on diabetic foot infections (DFIs) and the highest SUVmax was 4.2 (higher than the cutoff of 1.1) Despite intensive treatment, the infection progressed, leading to the patient undergoing right below knee amputation 43 days after SPECT/CT. (Bottom) Mild focal abnormal leukocyte accumulation was detected in the right 3rd and 4th toes. The lesions were in contact with the bone, which raised a suspicion of osteomyelitis (left panel, MIP image; right panel, axial SPECT/CT). A circular VOI was drawn on DFIs and the SUVmax was 1.0 (lower than the cutoff of 1.1). After 10 weeks of antibiotic treatment, the infection was successfully resolved, and the foot was preserved. Image and caption courtesy of Scientific Reports.
Deep-learning algorithm improves liver fibrosis diagnosis
By Amerigo Allegretto
An algorithm combining the Fibrosis-4 Index and an ultrasound deep-learning model could improve diagnostic accuracy for advanced liver fibrosis.
April 23, 2024
Ultrasound Scanner Ultraviolet 400
Novel risk prediction model improves LCS uptake
By Kate Madden Yee
A novel risk prediction model used in the Ontario Lung Cancer Screening Pilot increased the uptake of lung cancer screening among eligible Canadians, researchers have found.
April 23, 2024
Lung Cancer
PET/CT superior to MRI for detecting spinal bone metastases
By Will Morton
Gallium-68 DOTATATE PET/CT appears to be the best approach for detecting spinal bone metastases in patients with certain neuroendocrine tumors.
April 23, 2024
Ppgl 167 250
NLP uncovers racial bias in documenting ob/gyn imaging findings
By Amerigo Allegretto
Natural language processing (NLP), a form of AI, can uncover racial bias in documenting radiology-confirmed ob/gyn findings.
April 23, 2024
Chat Gpt Artificial Intelligence Ai Head
Neuroimaging detects blast exposure brain injuries in U.S. soldiers
By Will Morton
A battery of MRI and PET neuroimaging tests show patterns of brain injury in active-duty U.S. soldiers caused by repeated blast exposures.
April 22, 2024
Military
Page 1 of 3588
Next Page